TY - JOUR
T1 - Peptone from casein, an antagonist of nonribosomal peptide synthesis
T2 - a case study of pedopeptins produced by Pedobacter lusitanus NL19
AU - Covas, Cláudia
AU - Almeida, Beatriz
AU - Esteves, Ana Cristina
AU - Lourenço, Joana
AU - Domingues, Pedro
AU - Caetano, Tânia
AU - Mendo, Sónia
N1 - Funding Information:
Cláudia Covas was supported by Fundação para a Ciência e Tecnologia (FCT), POPH and European Union grant SFRH/BD/98446/2013. Tânia Caetano (TC) and Joana Lourenço were supported by Fundação para a Ciência e Tecnologia (FCT), POPH and European Union grants SFRH/BPD/77900/2011 and SFRH/BPD/92554/2013 and also by national funds (OE), through FCT – Fundação para a Ciência e a Tecnologia, I.P. in the scope of the framework contract foreseen in the numbers 4, 5 and 6 of the article 23, of the Decree-Law 57/2016, of August 29, changed by Law 57/2017, of July 19 (TC contract award CEECIND/01463/2017). Thanks are due to FCT/MCTES for the financial support to CESAM (UIDP/50017/2020 + UIDB/50017/2020), QOPNA (FCT UID/QUI/00062/2019) and Portuguese Mass Spectrometry Network (LISBOA-01-0145-FEDER-402-022125) through national funds, to the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. Thanks are due to FCT/MCTES, for the financial support of Center for Interdisciplinary Research in Health (UID/MULTI/4279/2019). Thanks are also due to FCT and UCP for the CEEC institutional financing of AC Esteves. We also would like to thank Prof. Dr. Gabriele Bierbaum from the Institut für Medizinische Mikrobiologie, Immunologie und Parasitologie (IMMIP) - Universitätsklinikum Bonn – Germany for kindly providing the yeast species.
Funding Information:
Cláudia Covas was supported by Fundação para a Ciência e Tecnologia (FCT) , POPH and European Union grant SFRH/BD/98446/2013 . Tânia Caetano (TC) and Joana Lourenço were supported by Fundação para a Ciência e Tecnologia (FCT), POPH and European Union grants SFRH/BPD/77900/2011 and SFRH/BPD/92554/2013 and also by national funds (OE), through FCT – Fundação para a Ciência e a Tecnologia, I.P., in the scope of the framework contract foreseen in the numbers 4, 5 and 6 of the article 23, of the Decree-Law 57/2016, of August 29, changed by Law 57/2017, of July 19 (TC contract award CEECIND/01463/2017). Thanks are due to FCT/MCTES for the financial support to CESAM (UIDP/50017/2020 + UIDB/50017/2020), QOPNA (FCT UID/QUI/00062/2019) and Portuguese Mass Spectrometry Network (LISBOA-01-0145-FEDER-402-022125) through national funds, to the co-funding by the FEDER , within the PT2020 Partnership Agreement and Compete 2020. Thanks are due to FCT/MCTES, for the financial support of Center for Interdisciplinary Research in Health ( UID/MULTI/4279/2019 ). Thanks are also due to FCT and UCP for the CEEC institutional financing of AC Esteves . We also would like to thank Prof. Dr. Gabriele Bierbaum from the Institut für Medizinische Mikrobiologie, Immunologie und Parasitologie (IMMIP) - Universitätsklinikum Bonn – Germany for kindly providing the yeast species.
Publisher Copyright:
© 2020
PY - 2021/1/25
Y1 - 2021/1/25
N2 - Novel natural products are urgently needed to address the worldwide incidence of bacterial resistance to antibiotics. Extreme environments are a major source of novel compounds with unusual chemical structures. Pedobacter lusitanus NL19 is a new bacterial species that was isolated from one such environment and which produces compounds with potent activity against relevant microorganisms in the clinical, food, veterinary and aquaculture areas. The production of antimicrobials by P. lusitanus NL19 was identified in tryptic soy agar (TSA), but not in its equivalent broth (TSB). It was observed that in TSB medium a high concentration of casein peptone (PC) repressed the production of antibacterial compounds. HPLC, MS and MS/MS spectra with de novo sequencing revealed that the bioactivity of P. lusitanus NL19 was due to the production of pedopeptins. Hence, biosynthesis of pedopeptins is inhibited by high concentrations of PC in the broth medium. Furthermore, a nonribosomal peptide synthetase (NRPS) gene cluster was identified in the genome of NL19 encoding the biosynthesis of the peptides. qPCR analysis confirmed that the transcription of these genes is repressed in cells cultivated in high concentrations of PC. It is shown that pedopeptins are nonribosomal peptides with a broad-spectrum activity, including against Gram-positive and Gram-negative bacteria and yeasts.
AB - Novel natural products are urgently needed to address the worldwide incidence of bacterial resistance to antibiotics. Extreme environments are a major source of novel compounds with unusual chemical structures. Pedobacter lusitanus NL19 is a new bacterial species that was isolated from one such environment and which produces compounds with potent activity against relevant microorganisms in the clinical, food, veterinary and aquaculture areas. The production of antimicrobials by P. lusitanus NL19 was identified in tryptic soy agar (TSA), but not in its equivalent broth (TSB). It was observed that in TSB medium a high concentration of casein peptone (PC) repressed the production of antibacterial compounds. HPLC, MS and MS/MS spectra with de novo sequencing revealed that the bioactivity of P. lusitanus NL19 was due to the production of pedopeptins. Hence, biosynthesis of pedopeptins is inhibited by high concentrations of PC in the broth medium. Furthermore, a nonribosomal peptide synthetase (NRPS) gene cluster was identified in the genome of NL19 encoding the biosynthesis of the peptides. qPCR analysis confirmed that the transcription of these genes is repressed in cells cultivated in high concentrations of PC. It is shown that pedopeptins are nonribosomal peptides with a broad-spectrum activity, including against Gram-positive and Gram-negative bacteria and yeasts.
KW - Antimicrobial activity
KW - Casein peptone
KW - Extreme environments
KW - NRPS
KW - Pedopeptins
KW - qPCR
UR - http://www.scopus.com/inward/record.url?scp=85090898610&partnerID=8YFLogxK
U2 - 10.1016/j.nbt.2020.07.006
DO - 10.1016/j.nbt.2020.07.006
M3 - Article
C2 - 32891869
AN - SCOPUS:85090898610
SN - 1871-6784
VL - 60
SP - 62
EP - 71
JO - New Biotechnology
JF - New Biotechnology
ER -